Transgenomic Company Profile (NASDAQ:TBIO)

About Transgenomic

Transgenomic logoTransgenomic, Inc. is a biotechnology company. The Company is engaged in advancing personalized medicine for the detection and treatment of cancer, and inherited diseases through its molecular technologies and clinical and research services. The Company operates through its Laboratory Services segment. The Company is engaged in the provision of its Multiplexed ICE COLD-PCR (MX-ICP) product to the clinical market, enabling the use of blood and other bodily fluids for diagnosis, monitoring and treatment of cancer. MX-ICP amplifies the ability to detect genetic mutations by approximately 100 to 400 fold. MX-ICP is validated internally on sequencing platforms, including Sanger, Next Gen Sequencing and Digital polymerase chain reaction (PCR). Its laboratory in Omaha, Nebraska is focused on providing genetic analytical services related to oncology and pharmacogenomics research services supporting Phase II and Phase III clinical trials conducted by pharmaceutical and biotechnology companies.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Scientific & Technical Instruments
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: TBIO
  • CUSIP:
Key Metrics:
  • Previous Close: $0.30
  • 50 Day Moving Average: $0.3260
  • 200 Day Moving Average: $0.5137
  • 52-Week Range: $0.25 - $1.48
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -0.14
  • P/E Growth: 0.0000
  • Market Cap: $7.07M
  • Outstanding Shares: 23,547,000
  • Beta: 0.15
Profitability:
  • Return on Equity: -143.12%
  • Return on Assets: -35.73%
Debt:
  • Current Ratio: 0.10%
  • Quick Ratio: 0.10%
Additional Links:
Companies Related to Transgenomic:

Analyst Ratings

Consensus Ratings for Transgenomic (NASDAQ:TBIO) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Transgenomic (NASDAQ:TBIO)
Show:
DateFirmActionRatingPrice TargetDetails
8/14/2015Craig HallumLower Price TargetBuy$8.00View Rating Details
(Data available from 9/28/2014 forward)

Earnings

Earnings History for Transgenomic (NASDAQ:TBIO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/10/2016        
8/12/2016Q216($0.10)ViewListenView Earnings Details
5/24/2016Q116($0.10)ViewListenView Earnings Details
11/12/2015Q315($0.27)($0.18)$6.65 million$4.00 millionViewListenView Earnings Details
8/13/2015Q215($0.41)($0.30)$7.10 million$7.00 millionViewListenView Earnings Details
5/14/2015Q115($0.52)($0.36)$6.80 million$6.51 millionViewListenView Earnings Details
4/15/2015Q414($0.56)($0.77)$6.20 million$7.70 millionViewN/AView Earnings Details
10/30/2014($0.58)($0.61)ViewN/AView Earnings Details
5/7/2014($0.47)($0.60)ViewN/AView Earnings Details
3/12/2014($0.36)($0.05)ViewN/AView Earnings Details
8/6/20132Q13($0.03)($0.03)ViewN/AView Earnings Details
5/8/20131Q13($0.03)($0.04)ViewN/AView Earnings Details
3/13/20134Q12($0.03)($0.03)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Transgenomic (NASDAQ:TBIO)
Current Year EPS Consensus Estimate: $-1.4500 EPS
Next Year EPS Consensus Estimate: $-2.1400 EPS

Dividends

Dividend History for Transgenomic (NASDAQ:TBIO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Transgenomic (NASDAQ:TBIO)
Insider Ownership Percentage: 1.90%
Institutional Ownership Percentage: 35.60%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/22/2014Leroy C KoppMajor ShareholderSell413,050$3.70$1,528,285.00View SEC Filing  
10/2/2013Leroy C KoppMajor ShareholderBuy9,000$0.39$3,510.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Transgenomic (NASDAQ:TBIO)
DateHeadline
News IconVolume Buzzers on Charts: Novatel Wireless Inc. (NASDAQ:MIFI), Transgenomic Inc. (NASDAQ:TBIO) - Street Wise Report (press release) (blog) (NASDAQ:TBIO)
streetwisereport.com - September 26 at 11:42 AM
News IconHot News- CenturyLink, Inc. (NYSE:CTL), Transgenomic Inc. (NASDAQ:TBIO) - Seneca Globe (NASDAQ:TBIO)
www.senecaglobe.com - September 26 at 11:42 AM
biz.yahoo.com logoTRANSGENOMIC INC Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:TBIO)
biz.yahoo.com - September 23 at 6:58 PM
businesswire.com logoTransgenomic and Ventana Medical Systems Complete Data Sharing Agreement - Business Wire (press release) (NASDAQ:TBIO)
www.businesswire.com - September 22 at 10:31 AM
publicnow.com logoTransgenomic and Ventana Medical Systems Complete Data Sharing Agreement (NASDAQ:TBIO)
www.publicnow.com - September 22 at 10:31 AM
News IconPenny Stock Investors Take an Interest in Transgenomic Inc. (NASDAQ:TBIO) - Duncan Research (NASDAQ:TBIO)
www.duncanindependent.com - September 21 at 11:41 AM
biz.yahoo.com logoTRANSGENOMIC INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; (NASDAQ:TBIO)
biz.yahoo.com - August 29 at 7:36 PM
finance.yahoo.com logoEdited Transcript of TBIO earnings conference call or presentation 12-Aug-16 9:00pm GMT (NASDAQ:TBIO)
finance.yahoo.com - August 26 at 7:22 PM
finance.yahoo.com logoTRANSGENOMIC INC Financials (NASDAQ:TBIO)
finance.yahoo.com - August 25 at 7:57 PM
capitalcube.com logoETF’s with exposure to Transgenomic, Inc. : August 17, 2016 (NASDAQ:TBIO)
www.capitalcube.com - August 17 at 8:02 PM
capitalcube.com logoTransgenomic, Inc. :TBIO-US: Earnings Analysis: Q2, 2016 By the Numbers : August 16, 2016 (NASDAQ:TBIO)
www.capitalcube.com - August 16 at 7:49 PM
News IconTransgenomic, Inc. Reports Second Quarter 2016 Financial Results (NASDAQ:TBIO)
www.biospace.com - August 15 at 8:03 PM
nasdaq.com logoHCP's Big Dividend And Its New QCP Risks (NASDAQ:TBIO)
www.nasdaq.com - August 13 at 10:32 AM
biz.yahoo.com logoTRANSGENOMIC INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits (NASDAQ:TBIO)
biz.yahoo.com - August 12 at 7:52 PM
publicnow.com logoTransgenomic Reports Second Quarter 2016 Financial Results (NASDAQ:TBIO)
www.publicnow.com - August 12 at 7:52 PM
biz.yahoo.com logoQ2 2016 Transgenomic Inc Earnings Release - After Market Close (NASDAQ:TBIO)
biz.yahoo.com - August 12 at 10:57 AM
News IconStock Update on Transgenomic Inc. (NASDAQ:TBIO) - Duncan Research (NASDAQ:TBIO)
www.duncanindependent.com - August 11 at 8:17 PM
publicnow.com logoTransgenomic to Hold Second Quarter 2016 Results Conference Call on August 12, 2016 at 5:00 PM EDT (NASDAQ:TBIO)
www.publicnow.com - August 10 at 8:15 PM
News IconVWR to Distribute Transgenomics ICEme Kits That Enable Liquid Biopsy-Based Cancer Research on Existing Platforms (NASDAQ:TBIO)
www.cbs58.com - August 9 at 8:01 PM
4-traders.com logoTransgenomic : VWR to Distribute Transgenomic’s ICEme Kits That Enable Liquid Biopsy-Based Cancer Research on Existing Platforms (NASDAQ:TBIO)
www.4-traders.com - August 9 at 8:01 PM
businesswire.com logoVWR to Distribute Transgenomic's ICEme Kits That Enable Liquid Biopsy-Based Cancer Research on Existing Platforms - Business Wire (press release) (NASDAQ:TBIO)
www.businesswire.com - August 8 at 10:50 AM
publicnow.com logoVWR to Distribute Transgenomic’s ICEme Kits that Enable Liquid Biopsy-Based Cancer Research on Existing Platforms (NASDAQ:TBIO)
www.publicnow.com - August 8 at 10:50 AM
tmcnet.com logoTransgenomic Launches First Commercially Available CLIA Test for … (NASDAQ:TBIO)
www.tmcnet.com - July 26 at 8:10 PM
streetinsider.com logoTransgenomic (TBIO) Announces Launch of New CLIA Assays (NASDAQ:TBIO)
www.streetinsider.com - July 26 at 8:10 PM
capitalcube.com logoETF’s with exposure to Transgenomic, Inc. : July 26, 2016 (NASDAQ:TBIO)
www.capitalcube.com - July 26 at 1:01 PM
streetinsider.com logoTransgenomic (TBIO) Announces Launch of New CLIA Assays - StreetInsider.com (NASDAQ:TBIO)
www.streetinsider.com - July 25 at 10:49 AM
publicnow.com logoTransgenomic Launches First Commercially Available CLIA Test for Detection of EGFR C797S Mutations that Predict Resistance to 3rd Generation Kinase Therapies for Lung Cancer (NASDAQ:TBIO)
www.publicnow.com - July 25 at 7:58 AM
News IconTransgenomic Licenses Commercial Rights To Its Long QT Syndrome DNA Testing Portfolio To LabCorp - Laboratory Network (NASDAQ:TBIO)
www.laboratorynetwork.com - July 23 at 11:29 AM
News IconTransgenomic Incorporated (NASDAQ:TBIO) Short Interest Decreased By 9.95% - Consumer Eagle (NASDAQ:TBIO)
www.consumereagle.com - July 23 at 11:29 AM
4-traders.com logoTransgenomic : Licenses Commercial Rights to Its Long QT Syndrome DNA Testing Portfolio to LabCorp (NASDAQ:TBIO)
www.4-traders.com - July 21 at 8:05 PM
streetinsider.com logoPre-Open Stock Movers 07/20: (PGNX) (TBIO) (GLBL) Higher; (ZFGN) (EVOK) (RYI) Lower (more...) - StreetInsider.com (NASDAQ:TBIO)
www.streetinsider.com - July 20 at 10:38 AM
News IconTransgenomic Incorporated (NASDAQ:TBIO) Sellers Covered 37.88% of Their Shorts - Consumer Eagle (NASDAQ:TBIO)
www.consumereagle.com - July 20 at 10:38 AM
streetinsider.com logoTransgenomic (TBIO) Licenses Long QT Syndrome DNA Testing Portfolio to LabCorp (LH) - StreetInsider.com (NASDAQ:TBIO)
www.streetinsider.com - July 20 at 10:38 AM
News IconTransgenomic Inc (NASDAQ:TBIO) Move Down as Institutional Investors' Sentiment Improved - Press Telegraph (NASDAQ:TBIO)
presstelegraph.com - July 15 at 6:41 PM
News IconTransgenomic Incorporated (NASDAQ:TBIO) Short Interest Decreased By 37.88% - Consumer Eagle (NASDAQ:TBIO)
www.consumereagle.com - July 13 at 8:06 PM
News IconIs Major Move Coming For Transgenomic Inc After This Double Bottom Pattern? - Consumer Eagle (NASDAQ:TBIO)
www.consumereagle.com - July 12 at 12:03 PM
News IconTransgenomic Incorporated (NASDAQ:TBIO) Short Interest Decreased By 37.88% - Press Telegraph (NASDAQ:TBIO)
presstelegraph.com - July 2 at 7:11 PM
News IconTransgenomic Incorporated (NASDAQ:TBIO) Short Interest Decreased By 37.88% - Engelwood Daily (NASDAQ:TBIO)
www.engelwooddaily.com - June 29 at 7:39 PM
News IconTransgenomic Incorporated (NASDAQ:TBIO) Short Interest Increased By 9.88% - Engelwood Daily (NASDAQ:TBIO)
www.engelwooddaily.com - June 25 at 11:22 AM
4-traders.com logoTransgenomic : Accelerates Commercialization of ICE COLD-PCR ICP amid Plans to Expand Cancer Product Line Ten-Fold (NASDAQ:TBIO)
www.4-traders.com - June 23 at 8:26 PM
investornewswire.com logoStrong Buy Calls Count For Transgenomic, Inc. (NASDAQ:TBIO) At 1 - Investor Newswire (NASDAQ:TBIO)
www.investornewswire.com - June 17 at 7:25 PM
News IconInvestor News: Transgenomic Inc (NASDAQ:TBIO) faces Investigation - GroundReport (NASDAQ:TBIO)
www.groundreport.com - June 17 at 7:25 PM
News IconInvestor News: Transgenomic Inc (NASDAQ:TBIO) faces Investigation (NASDAQ:TBIO)
www.groundreport.com - June 16 at 12:07 PM
streetinsider.com logoTransgenomic (TBIO) Announces Expansion of ICE COLD-PCR (ICP)-Powered Cancer Assays - StreetInsider.com (NASDAQ:TBIO)
www.streetinsider.com - June 15 at 10:22 AM
publicnow.com logoTransgenomic Accelerates Commercialization of ICE COLD-PCR (ICP) Amid Plans To Expand Cancer Product Line Ten-Fold (NASDAQ:TBIO)
www.publicnow.com - June 14 at 7:39 AM
News IconInvestigation of Transgenomic Inc (NASDAQ:TBIO) for Investors Announced - Digital Journal (NASDAQ:TBIO)
www.digitaljournal.com - June 9 at 8:13 PM
biz.yahoo.com logoTRANSGENOMIC INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Oblig (NASDAQ:TBIO)
biz.yahoo.com - June 7 at 5:17 PM
streetinsider.com logoTransgenomic (TBIO) to Present New ICE COLD-PCR Tech Data at ASCO - StreetInsider.com (NASDAQ:TBIO)
www.streetinsider.com - June 7 at 10:34 AM
publicnow.com logoTransgenomic Releases New Data at ASCO 2016 Conference Confirming Concordance of ICE COLD-PCR (ICP) Liquid and Tissue Biopsies (NASDAQ:TBIO)
www.publicnow.com - June 7 at 7:28 AM
finance.yahoo.com logoTransgenomic Releases New Data at ASCO 2016 Confirming Concordance of ICE COLD-PCR (ICP) Liquid and Tissue Biopsies (NASDAQ:TBIO)
finance.yahoo.com - June 7 at 7:15 AM

Social

Transgenomic (NASDAQ:TBIO) Chart for Wednesday, September, 28, 2016


Last Updated on 9/28/2016 by MarketBeat.com Staff